TB questions

A patient is receiving the antitubercular medication streptomycin. Which of these statements made by the patient would alert the healthcare provider that the patient is experiencing a common adverse effect from the medication? Please choose from one of the following options. A "It burns when I urinate." B "I sometimes see flashing lights." C "I feel bloated and full of gas." D "I feel dizzy and my ears are ringing."

"I feel dizzy and my ears are ringing."

The healthcare provider is teaching a student how to administer a tuberculin skin test (TST). Which of the following statements describes the correct technique? Please choose from one of the following options. A "Pinch the skin slightly before inserting the needle." B "Be sure to massage the area after you remove the needle." C "Hold the syringe at a 45 degree angle." D "Keep the bevel of the needle up."

"Keep the bevel of the needle up."

When reading a patient's tuberculin skin test (TST), the healthcare provider notes 5 mm of redness and 2 mm of induration. The correct reading for this patient is __ mm. Please choose from one of the following options. A 2 B 3 C 5 D 7

2

The healthcare provider is evaluating the tuberculin skin test (TST) for a patient who has a diagnosis of human immunodeficiency virus (HIV). The skin test is positive if the area of induration is at least __ mm? Please choose from one of the following options. A) 1 B) 5 C) 10 D) 15

5

Which type of infection control measures should the healthcare provider put in place for a patient who is being admitted with a diagnosis of active pulmonary tuberculosis (TB)? Please choose from one of the following options. A Positive pressure ventilation B Droplet precautions C Airborne precautions D Contact precautions

Airborne precautions

A woman in her first trimester of pregnancy is diagnosed with tuberculosis (TB) disease. Which of these interventions will the healthcare provider implement? Please choose from one of the following options. A Begin treatment with antituberculous medications immediately. B Wait until after the baby is born because antituberculous medications harm the fetus. C Begin treatment with antituberculosis medications but decrease the daily dose. D Delay treatment until after the results of an amniocentesis is available.

Begin treatment with antituberculosis medications but decrease the daily dose.

During the screening process for tuberculosis (TB), the healthcare provider notes that the patient received the bacilli Calmette-Guérin (BCG) vaccination several years ago. Which of the following is the best method to determine this patient's TB status? Please choose from one of the following options. A Computerized tomography (CT) B Interferon-gamma release assay (IGRA) C Bronchoscopy for acid-fast bacteria (AFB) smear and culture D Tuberculin skin test (TST)

Interferon-gamma release assay (IGRA)

When caring for a patient who has been diagnosed with active tuberculosis, which of the following personal protection equipment will the healthcare provider wear? Please choose from one of the following options. A Sterile gloves B Eye goggles C Surgical mask D Personal respirator

Personal respirator

The tuberculin skin test (TST) results for a patient who has been diagnosed with human immunodeficiency virus (HIV) is negative. How should the healthcare provider interpret this test result? Please choose from one of the following options. A Poor technique was used when administering the TST. B The patient has not been exposed to the tuberculosis bacteria. C The examiner failed to palpate the patient's arm thoroughly. D The patient is unable to mount an immune response to the test

The patient is unable to mount an immune response to the test

The healthcare provider administers a tuberculin skin test (TST) to a patient and gives instructions to return in 48 to 72 hours so the results can be interpreted. These instructions are based on the knowledge that a positive TST is the result of a _ hypersensitivity reaction. Please choose from one of the following options. A Type I B Type II C Type III D Type IV

Type IV